ONYA THERAPEUTICS LIMITED

Active Ebbw Vale

Research and experimental development on biotechnology

7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
O

ONYA THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 5 Feb 2020 Active Ebbw Vale, United Kingdom 7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 30 Sept 2026 3 months remaining
Confirmation
Net assets £-1M £67K 2024 year on year
Total assets £311K £141K 2024 year on year
Total Liabilities £1M £208K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Innovation Centre Festival Drive Ebbw Vale NP23 8XA United Kingdom

Website

www.example.com

Full company profile for ONYA THERAPEUTICS LIMITED (12443293), an active life sciences and medical technology company based in Ebbw Vale, United Kingdom. Incorporated 5 Feb 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£190.87k

Increased by £149.37k (+360%)

Net Assets

-£1.10M

Decreased by £67.16k (-7%)

Total Liabilities

£1.41M

Increased by £208.32k (+17%)

Turnover

N/A

Employees

7

Debt Ratio

453%

Decreased by 254 (-36%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jan 2025Seed
Investor 2Jan 2025Seed

Share Capital

Share Capital

Share allotments and capital structure

143 Allotments 11,933,506 Shares £26.88m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Mar 2026268,643£19k£19k
30 Mar 2026268,643£19k£19k
27 Mar 20265,372£19k£19k
27 Mar 20265,372£19k£19k
11 Feb 20265,372£186k£186k

Officers

Officers

3 active
Status
Hafner, Thomas ChristianDirectorGermanUnited Kingdom625 Feb 2020Active
Marron, Damian JohnDirectorBritishFrance631 Dec 2022Active
Pigg, William, DrDirectorBritishEngland6410 Aug 2020Active

Shareholders

Shareholders (28)

Timothy Hafner
32.9%
1,075,453
Lucas Maximilian Hafner
32.9%
1,075,452

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Mr Timothy Calvin Hafner

Dutch

Active
Notified 17 Nov 2025
Residence Malta
DOB February 1999
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Mr Lucas Maximilian Hafner

Dutch

Active
Notified 17 Nov 2025
Residence Malta
DOB January 2001
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Neem Biotech Ltd

Ceased 1 Jan 2022

Ceased

Ctl Familienstiftung

Ceased 17 Nov 2025

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Jun 2026MiscellaneousReplacement filing of SH01 - 30/03/26 Statement of Capital gbp 7.103608
4 Jun 2026MiscellaneousReplacement filing of SH01 - 27/03/26 Statement of Capital gbp 6.559526
2 Jun 2026MiscellaneousReplacement filing of SH01 - 31/12/25 Statement of Capital gbp 6.54
1 Jun 2026MiscellaneousReplacement filing of SH01 - 11/02/26 Statement of Capital gbp 6.549526
1 Jun 2026MiscellaneousReplacement filing of SH01 - 07/01/26 Statement of Capital gbp 6.5
4 Jun 2026 Miscellaneous

Replacement filing of SH01 - 30/03/26 Statement of Capital gbp 7.103608

4 Jun 2026 Miscellaneous

Replacement filing of SH01 - 27/03/26 Statement of Capital gbp 6.559526

2 Jun 2026 Miscellaneous

Replacement filing of SH01 - 31/12/25 Statement of Capital gbp 6.54

1 Jun 2026 Miscellaneous

Replacement filing of SH01 - 11/02/26 Statement of Capital gbp 6.549526

1 Jun 2026 Miscellaneous

Replacement filing of SH01 - 07/01/26 Statement of Capital gbp 6.5

Recent Activity

Latest Activity

Replacement filing of SH01 - 30/03/26 Statement of Capital gbp 7.103608

6 days ago on 4 Jun 2026

Replacement filing of SH01 - 27/03/26 Statement of Capital gbp 6.559526

6 days ago on 4 Jun 2026

Replacement filing of SH01 - 31/12/25 Statement of Capital gbp 6.54

1 weeks ago on 2 Jun 2026

Replacement filing of SH01 - 11/02/26 Statement of Capital gbp 6.549526

1 weeks ago on 1 Jun 2026

Replacement filing of SH01 - 07/01/26 Statement of Capital gbp 6.5

1 weeks ago on 1 Jun 2026